NioCorp Developments
Development-stage miner: no operating revenue; spends equity/government capital to permit, engineer and build the Elk Creek mine + processing plant, with value tied to a project-financing close (EXIM Bank debt) and future niobium/scandium/titanium/REE production.
Earnings, margins, COGS & capex
No revenue. NioCorp is a single-asset development company whose income statement is dominated by exploration/G&A cash burn plus large non-cash swings from SPAC-legacy earnout shares and warrant-liability fair-value changes (it listed on Nasdaq via a March 2023 SPAC merger with GX Acquisition Corp II and subsequently delisted from the TSX). The story on the balance sheet: a ~$421M cash war chest as of 2026-03-31, built mostly from ~19.3M warrant exercises and equity raises during a share-price run-up, funding the pre-construction phase while it pursues a ~$780-800M EXIM Bank project-debt package.
Revenue trend
Margins
will not exist until Elk Creek reaches production
reported loss distorted by earnout/warrant fair-value marks
swing item, not recurring earnings
COGS structure
No COGS - nothing is produced or sold. Future unit economics hinge on the FS operating cost structure (ferroniobium, scandium oxide, titanium dioxide) and prevailing commodity prices, none realized yet.
Capex
Elk Creek is the entire capex thesis: 2022 FS total up-front capital ~$1.14B (US$1,141M, comprising direct + indirect + pre-production + contingency, net of a pre-production revenue credit), on a 2022 cost basis now dated by inflation. Early portal/decline construction underway ($44.6M budget). Full build is contingent on closing the ~$780-800M EXIM debt package plus equity/strategic capital.
Latest earnings
Not a revenue/EPS-beat story; headline net income of $669K was a non-cash fair-value gain. The 'result' investors watch is the cash balance and financing progress.
No revenue guidance (pre-production). Company signals targeting a 2026 financing decision and start of construction; pursuing a ~$780-800M EXIM Bank debt package and up to $10M of DOD (Department of War) milestone reimbursement.
- Cash + restricted (2026-03-31)
- $421.3M
- Total assets
- $469.0M
- Total liabilities
- $34.6M
- Shareholders' equity
- $435.4M
- Working capital
- $409.9M
- Shares outstanding
- 145.3M
- Warrant exercises (9mo FY2026)
- 19.3M shares
- Exploration spend (9mo)
- $13.4M
Growth drivers
- Closing project financing — the ~$780-800M US EXIM Bank debt application (reportedly advancing under an EXIM initiative dubbed 'Project Vault') is the single largest catalyst; a close unlocks construction
- US critical-minerals policy tailwind — Elk Creek is pitched as North America's only near-term primary niobium/scandium source, aligned with reshoring and defense supply-chain security
- Scandium/aluminum-scandium alloy demand via the Lockheed Martin Skunk Works Pentagon-funded program (lightweight aerospace/defense alloys)
- Rare-earth optionality — Elk Creek is cited as the 2nd-largest indicated-or-better REE resource in the US, an add-on to the base niobium/scandium/titanium plan
- Updated/expanded feasibility economics at higher current commodity prices vs the 2022 FS
Bull & bear
A rare, permitted, US-domiciled source of niobium and scandium arriving exactly as Washington pays to reshore critical-minerals supply chains - with a fortress ~$421M cash balance and a near-term government-backed financing catalyst that, if it closes, converts a speculative developer into a funded builder.
- 2022 FS after-tax NPV ~$2.35B at an 8% discount (27.6% after-tax IRR) - roughly 3.4x the current ~$690M market cap, before any further REE upside or higher current commodity prices
- ~$421M cash with negligible debt means near-term financing dilution is cushioned and the company controls its own timeline
- US EXIM Bank considering a ~$780-800M debt package plus DOD funding and a Lockheed Martin alloy program - policy and defense demand are actively pulling the project forward
- Only near-term primary niobium and scandium project in North America - genuine supply-security scarcity value to steelmakers, aerospace and defense
- Optionality stack: base niobium/scandium/titanium plan plus the 2nd-largest indicated US REE resource as a free-ish call option
A pre-revenue, single-asset developer whose ~$690M valuation already capitalizes a financing and construction outcome that hasn't happened - facing a ~$1.14B (and rising) funding gap, an opaque niobium market controlled by a far lower-cost incumbent, and a track record of dilution that keeps eroding per-share value.
- No revenue, no production, and the 2022 FS economics rest on a 2022 cost basis - real build capex is materially higher today and not yet fully financed
- The equity is binary on the EXIM/DOD financing close; a delay or failure removes the core catalyst and the cash burn continues
- Niobium is ~75-80% supplied by Brazil's CBMM at very low cost - a new entrant has no pricing power and must prove it can compete on cost
- Scandium demand is still speculative; aluminum-scandium alloy adoption may not scale on the timeline the thesis needs
- Heavy warrant/earnout overhang and repeated equity raises dilute holders; GAAP 'profit' quarters are non-cash artifacts, not earnings
- 52-week range of $2.30-$12.58 shows the stock trades on sentiment and catalyst speculation, not fundamentals
What it is worth
NAV / project-NPV vs market cap, with a heavy risk discount for un-closed financing and pre-production status (standard for single-asset developers).
EXIM/DOD financing stalls or fails, capex gap and burn force dilutive raises, commodity/cost pressure compresses NPV; equity drifts back toward the $2-3 low end of the 52-wk range or below.
Company remains a well-capitalized developer inching toward a decision; stock oscillates with financing headlines in a wide band around current ~$4-5 levels; further dilution likely.
Financing closes and updated economics (higher niobium/scandium prices + REE co-product) hold NAV near or above the 2022 ~$2.35B after-tax figure; equity re-rates toward $10-12+ (near sell-side ~$11.63 avg target and prior 52-wk high $12.58).
Market cap ~$690M vs a 2022 FS after-tax NPV of ~$2.35B (8% discount, 27.6% IRR; pre-tax NPV ~$2.82B, 29.2% IRR) computed on 2022 costs/prices. The resulting ~0.3x P/NAV reflects the market pricing in financing risk, capex inflation and dilution. This is a binary, catalyst-driven valuation - it re-rates toward NAV on a financing close and de-rates hard on failure/delay. Not supported by any current earnings or cash flow.
SWOT
Strengths
- Fully permitted, shovel-ready single asset — highest-grade niobium resource in North America plus scandium, titanium and a large indicated REE resource
- Record ~$421M cash and essentially no debt as of 2026-03-31 — rare liquidity strength for a pre-revenue developer
- Strategic US-government alignment — Pentagon/DOD funding, an active ~$780-800M EXIM Bank debt application, and a Lockheed Martin Skunk Works alloy partnership
- Multi-product basket (Nb + Sc + Ti + REE) diversifies commodity exposure vs single-metal peers
Weaknesses
- Zero revenue and years from production; every dollar is outflow
- Full build (~$1.14B per the 2022 FS, and higher on today's costs) is not yet financed - a large debt+equity gap remains
- History of dilution — share count and warrant/earnout overhang from the 2023 SPAC listing distort GAAP earnings and pressure per-share value
- Execution risk on a first-of-kind US niobium/scandium processing flowsheet at commercial scale
Opportunities
- EXIM/DOD financing close would de-risk the equity dramatically and could re-rate the stock
- Structural push to build non-China, non-Brazil critical-minerals supply chains (defense, EV, aerospace)
- Scandium is a nascent market — aluminum-scandium alloys could unlock a new, higher-margin demand curve if adoption scales
- REE co-product monetization as a bolt-on to the base case if prices and offtake support it
Threats
- Financing failure or delay - the whole thesis is binary on capital access
- Niobium pricing is opaque and dominated by low-cost incumbent CBMM, which could defend share and pressure economics
- Commodity-price and cost-inflation risk widening the funding gap
- Prolonged pre-revenue status forcing further dilutive raises — macro/rate environment affecting project debt terms
Moats, dependencies & bottlenecks
Moats
Long-lived (38-year FS mine life) Highest-grade niobium resource in North America plus a top-2 US indicated REE resource - not replicable at will
Moderate-Strong Full permitting is a multi-year barrier competitors would have to re-clear; a real head start
Policy-dependent DOD funding, EXIM consideration and Lockheed Martin partnership create sticky strategic relationships but hinge on continued US policy support
Sole near-term Western primary niobium/scandium source - valuable only if it can reach cost-competitive production
Dependencies
~$780-800M debt application under active consideration - the make-or-break dependency for construction
Up to $10M DOD reimbursement + broader critical-minerals policy; sensitive to administration priorities and budget
Has repeatedly funded via warrant exercises and equity raises; further raises likely and dilutive
Opaque, incumbent-set niobium pricing and a thin scandium market drive future economics
Commercial/demand Anchors a scandium-alloy demand narrative; early-stage, Pentagon-funded
First-of-kind US processing flowsheet at scale; cost/schedule overrun risk
Advantages
- ~$421M cash and near-zero debt - unusually strong balance sheet for a pre-revenue developer
- Only permitted, shovel-ready primary niobium + scandium project in North America
- Multi-product basket (Nb/Sc/Ti/REE) with embedded rare-earth optionality
- Direct US-government and defense-prime relationships (DOD, EXIM, Lockheed Martin)
Weaknesses
- No revenue and no production for years
- Unfinanced ~$1.14B+ build with a cost basis now dated by inflation
- Chronic dilution and a warrant/earnout overhang from the 2023 SPAC listing
- Valuation already discounts a successful, not-yet-achieved financing and build
Bottlenecks
- Closing the ~$780-800M EXIM debt package - construction cannot fully proceed without it
- The gap between the 2022-cost 2022 FS capex (~$1.14B) and today's real build cost
- Cost-competitiveness of a new entrant against CBMM's entrenched low-cost niobium supply
- Immature scandium end-market - demand must be created, not just captured
- Time-to-revenue: multi-year construction and ramp before any cash flow
Top signals & trends
Top signals
Extends runway and reduces near-term dilution pressure
The key catalyst; a close would re-rate the equity
Tangible progress toward build, but only ~$1.8M spent so far
Sentiment/catalyst-driven volatility; financing uncertainty weighing
Watch cash burn, not GAAP EPS
Bullish (with caveats) · Sparse, divergent coverage on a binary, financing-dependent story - treat with skepticism
Trends
Directly favors a domestic niobium/scandium source; underpins government funding
Nascent but strategically sponsored via Lockheed Martin/Pentagon
Positive optionality · Elevates the value of Elk Creek's REE co-product resource
Raises build cost and project-debt cost, widening the funding gap
Supply-security narrative for NioCorp, but incumbent cost advantage caps pricing power
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Build the mine, decline/portal and processing plant; cost/schedule partners (portal contracts ~$19.5M committed)
Mining and hydrometallurgical processing inputs for the Nb/Sc/Ti flowsheet
Ferroniobium buyers - niobium's primary end-use is high-strength low-alloy steel
Skunk Works aluminum-scandium alloy program - anchor scandium-demand relationship (Pentagon-funded)
Prospective scandium and titanium/REE offtakers as Western supply chains build out
Private, Brazil (Araxa). Dominant ~75-80% of global niobium at very low cost - the incumbent NioCorp must undercut or coexist with
Private, Quebec. The main other Western niobium producer (formerly IAMGOLD); a direct North American niobium comparable
Owns the Boa Vista (Catalao) niobium operation in Brazil - the world's #2 niobium producer after CBMM, a further low-cost incumbent constraining new-entrant pricing
NYSE. Largest Western rare-earth producer (Mountain Pass); sharply re-rated to a large multi-billion cap in 2025-26 on its DoD deal - the flagship US critical-minerals peer competing for policy capital and investor attention
NYSE American. Uranium + REE processing at White Mesa (multi-billion cap); competes as a US critical-minerals capital-markets peer
Nasdaq. US REE developer/magnet-maker; competes for the same reshoring narrative and capital
Largest non-China REE producer (Australia); benchmark for Western critical-minerals supply
Produces scandium oxide (Sorel-Tracy, Quebec) as a by-product - a competing scandium supply source